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Abstract
Survival studies often generate not only a survival time for each patient but
also a sequence of health measurements at annual or semi-annual check-ups
while the patient remains alive. Such a sequence of random length accompa-
nied by a survival time is called a survival process. Ordinarily robust health is
associated with longer survival, so the two parts of a survival process cannot
be assumed independent. This paper is concerned with a general technique—
reverse alignment—for constructing statistical models for survival processes.
A revival model is a regression model in the sense that it incorporates covari-
ate and treatment effects into both the distribution of survival times and the
joint distribution of health outcomes. The revival model also determines a
conditional survival distribution given the observed history, which describes
how the subsequent survival distribution is determined by the observed pro-
gression of health outcomes.
Keywords: interference; preferential sampling; quality-of-life; revival process; semi-
revival time; reverse alignment; stale values;
1 Survival studies
A survival study is one in which patients are recruited according to well-defined
selection criteria and their health status monitored on a regular or intermittent
schedule until the terminal event, here assumed to be fatal. Covariates such as sex
and age are recorded at the time of recruitment, and, if there is more than one
treatment level, the assignment is presumed to be randomized. In a simple survival
study, the health status Y (t) at time t is a binary variable, dead or alive, and the
entire process is then summarized by the time T > 0 spent in state 1, i.e., the
survival time. In a survival study with health monitoring, Y (t) is a more detailed
description of the state of health or quality of life of the individual, containing what-
ever information—pulse rate, cholesterol level, cognitive score or CD4 cell count—is
deemed relevant to the study. The goal may be to study the effect of treatment on
survival time, or to study its effect on quality of life, or to predict the subsequent
survival time of patients given their current health history.
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Survival studies with intermittent health monitoring are moderately common,
and likely to become more so as health records become available electronically for
research purposes. Within the past few years, several issues of the journal Lifetime
Data Analysis have been devoted to problems connected with studies of exactly
this type. For a good introduction, with examples and a discussion of scientific
objectives, see Diggle, Sousa and Chetwynd (2006), Kurland, Johnson, Egleston
and Diehr (2009) or Farewell and Henderson (2010). Section 8 of van Houwelingen
and Putter (2012) is recommended reading.
In practice, the patient’s health status is measured at recruitment (t = 0), and
regularly or intermittently thereafter while the patient remains alive. To emphasize
the distinction between the observation times and observation values, each time
is called an appointment date, the set of dates is called the appointment sched-
ule. Apart from covariate and treatment values, a complete uncensored observation
on one patient (T, t, Y [t]) consists of the survival time T > 0, the appointment
schedule t ⊂ [0, T ), and the health status measurements Y [t] at these times. To
accommodate patients whose record is incomplete, a censoring indicator variable is
also included. In that case, the censoring time is usually, but not necessarily, equal
to the date of the most recent appointment.
In the sense that the health status is measured over time on each patient, a
survival study is a particular sort of longitudinal study. Certainly, temporal and
other correlations are expected and must be accommodated. But the distinguishing
feature, that each sequence is terminated by failure or censoring, gives survival-
process models a very distinct character: as an absorbing state, death, contradicts
stationarity. For a good survey of the goals of such studies and the modeling
strategies employed, see Kurland, Johnson, Egleston and Diehr (2009).
The goal of this paper is not so much to recommend a particular statistical
model, as to explore a general mathematical framework for the construction of
survival-process models, permitting easy computation of the likelihood function
and parameter estimates, and straightforward derivation of predictive distributions
for individual survival times. For example, the paper has nothing to say on the
choice between proportional hazards and accelerated lifetimes for accommodating
treatment effects. Apart from reservations concerning the use of time-evolving co-
variates, all standard survival models are acceptable within the framework. Nor has
the paper anything to contribute to the choice between Bayesian and non-Bayesian
methods of analysis; prior distributions are not discussed, so either approach can be
used. Administrative complications of the sort that are inevitable in medical and
epidemiological research will be ignored for the most part, so no attempt is made
to provide a complete turnkey package. For example, the paper has little to say
about how best to handle incomplete records other than to recognize that censor-
ing and delayed reporting are issues that must be addressed—again using standard
well-developed methods. Since most of the computations needed for model fitting
and parameter estimation are relatively standard and need not involve specialized
Markov chain or Monte Carlo algorithms, detailed discussion of computational tech-
niques is omitted. The emphasis is on statistical ideas and principles, strategies for
model formulation, sampling schemes, and the distinction between time-dependent
variables and time-evolving variables in the definition of treatment effects.
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2 Reverse alignment
2.1 The survival process
A survival process Y is a stochastic process defined for real t, in which Yi(t) is
the state of health or quality of life of patient i at time t, usually measured from
recruitment. In a simple survival process, the state space R = {0, 1} is sufficient to
encode only the most basic of vital signs, dead or alive; more generally, the state
space is any set large enough to encode the observable state of health or quality of life
of the patient at one instant in time. Flatlining is the distinguishing characteristic
of a survival process, i.e., [ ∈ R is an absorbing state such that Y (t) = [ implies
Y (t′) = [ for all t′ ≥ t. The survival time is the time to failure:
Ti = sup
t≥0
{t : Yi(t) 6= [};
it is presumed that Yi(0) 6= [ at recruitment, so Ti > 0. This definition is quite
general, and does not exclude immortality, i.e., T =∞ with positive probability. In
all of the models considered here, however, survival time is finite with probability
one.
2.2 Administrative and other schedules
Since the appointment schedule is a random subset t ⊂ [0, T ), it is obviously infor-
mative for survival: T > max(t). If better health is associated with longer survival,
we should expect patients who are initially frail to have shorter health records
than patients who are initially healthy. In other words, even if the trajectories for
distinct individuals may be identically distributed, the first component of a short
health-status record should not be expected to have the same distribution as the
first component of a longer record. On the contrary, any model such that record
length is independent of record values must be regarded as highly dubious for sur-
vival studies. It is necessary, therefore, to address the nature of the information
contained in t.
Consider a patient who has had appointments on k occasions t(k) = (t0 < · · · <
tk−1). The sequence Y [t(k)] of recorded health values may affect the scheduled
date tk for the next appointment: for example, patients in poor health needing
more careful monitoring may have short inter-appointment intervals. Whatever the
scheduled date may be, the appointment is null unless tk < T . The assumption
used in this paper is sequential conditional independence, namely that
tk ⊥ Y | (T, t(k), Y [t(k)]). (1)
In other words, the conditional distribution of the random interval tk − tk−1 may
depend on the observed history Y [t(k)], but not on the subsequent health trajectory
except through T . Here, tk may be infinite (or null) with positive probability, in
which case the recorded sequence is terminated at tk−1.
The schedule is said to be administrative if tk is a deterministic function of
the pair (t(k), Y [t(k)]), implying that the conditional distribution (1) is degenerate.
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Eventually, for some finite k, the patient dies or is censored at time T ∈ (tk−1, tk)
while the next appointment is pending, so the recorded schedule is t = t(k) =
t(k+1) ∩ [0, T ). Equivalently, the last recorded value is (tk, [).
While the sequential conditional independence assumption is mathematically
clear-cut, the situation in practice may be considerably more muddy. Consider,
for example, the CSL1 trial organized by the Copenhagen Study Group for Liver
Diseases in the 1960s to study the effect of prednisone on the survival of patients
diagnosed with liver cirrhosis. In this instance Y (·) is a composite blood coagula-
tion index called the prothrombin level: details can be found in Andersen, Hansen
and Keiding (1991). Beginning at death, the reverse-time mean intervals between
appointments are 77, 210 and 252 days, while the medians are 21, 166 and 293 days.
In other words, half of the patients who died had their final appointment within
the last three weeks of life. It is evident that the appointment intensity increases
as s → 0 in reverse time, which is not, in itself, a violation of (1). However, one
might surmise that the increased intensity is related to the patient’s state of health
or perception thereof. Condition (1) implies that the appointment intensity does
not depend on the blood coagulation index other than at earlier appointments, and
it is then unclear to what extent the condition may be violated by patient-initiated
appointments. Liestøl and Andersen (2002, section 4.1) note that 71 off-schedule
appointments occurred less than 10 days prior to death, the majority of which were
patient-initiated. They also examine the effect on hazard estimates of excluding
unscheduled prothrombin measurements.
Although we refer to Y (·) generically as the patient’s state of health, this de-
scription is not to be taken literally. The actual meaning depends on what has in
fact been measured: in general, Y (·) is only one component or one aspect of patient
health.
2.3 The revival process
On the assumption that the survival time is finite, the time-reversed process
Zi(s) = Yi(Ti − s)
is called the revival process. Thus, Zi(s) is the state of health of patient i at time
s prior to failure, and Zi(Ti) = Yi(0) is the value at recruitment. By construction,
Z(s) = [ for s < 0, and Z(s) 6= [ for s > 0. Although Z is defined in reverse time,
the temporal evolution via the survival process occurs in real time: by definition,
Z(·) is not observable component-wise until the patient dies. The transformation
Y 7→ (T,Z) is clearly invertible; it may appear trivial, and in a sense it is trivial.
Its one key property is that the revival process Z and the random variable T are
variation independent.
The chief motivation for time reversal has to do with the effective alignment of
patient records for comparison and signal extraction. Are the temporal patterns
likely to be more similar in two records aligned either by patient age or by recruit-
ment date, or are they likely to be more similar in records aligned by reverse age
(time remaining to failure)? Ultimately, the answer must depend on the context,
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Table 1: Average prothrombin levels indexed by T and t
Survival Time t after recruitment (yrs)
time (T ) 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8 8+
0–1 58.0
1–2 72.5 66.4
2–3 72.6 73.2 66.0
3–4 69.8 71.2 68.5 54.2
4–5 68.5 75.7 72.5 74.6 57.7
5–6 70.5 77.3 73.5 57.1 64.5 60.9
6–7 81.8 73.6 81.1 80.6 79.4 75.5 75.8
7–8 84.4 88.8 88.1 92.1 85.2 81.2 84.3 88.1
8+ 77.3 73.6 87.0 74.1 92.0 80.3 89.2 79.4 84.7
but the context of survival studies suggests that the latter may be more effective
than the former. Table 1 shows the averaged Y -values indexed by T and t for the
prothrombin example discussed in more detail in section 5. It should be borne in
mind that each cell is the average of 8–266 non-independent high-variability mea-
surements, the larger counts occurring in the upper left cells. Alignment by reverse
time is equivalent to counting leftwards from the main diagonal. Despite certain
anomalies in the table of averages, e.g. row 6, column 4, it is clear that reverse-time
is a more effective way of organizing the data to display the main trends in the
mean response: the forward- and reverse-time sums of squares (equally weighted)
are 543.0 and 1132.8 respectively, both on eight degrees of freedom.
Further confirmation is provided in Table 2, which shows the output from a
standard equally-weighted analysis of variance applied to the table of averages,
with three factors, row, column and diagonal (reverse time), denoted by R, C and D
respectively. Compared with the residual mean square of 23.7, there is considerable
excess variation associated with rows (116.8) and with the reverse-time factor (77.8),
but not so much with columns (34.0). In other words, the means in Table 1 are
expressible approximately as αT + βT−t. Figures 8.3 and 8.4 of van Houwelingen
and Putter (2012), which are not substantially different from Fig. 3 of this paper,
offer strong confirmation of this viewpoint in one further survival study involving
white blood cell counts for patients suffering from chronic myeloid leukemia. For
an application unrelated to survival, see example B of Cox and Snell (1981).
Table 2: ANOVA decomposition for Table 1
Source U/V ‖PUY ‖2 − ‖PVY ‖2 d.f. M.S.
Diagonal (R+ C +D)/(R+ C) 544.3 7 77.8
Column (R+ C +D)/(R+D) 237.9 7 34.0
Row (R+ C +D)/(C +D) 817.3 7 116.8
Residual RC/(R+ C +D) 497.2 21 23.7
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2.4 Covariates
In the absence of specific information to the contrary, responses for distinct units
are presumed to be identically distributed. In the great majority of situations,
specific information does exist in the form of covariates or classification variables
or relationships. A covariate is a function i 7→ xi on the units, in principle known
for all units whether they occur in the sample or not. A covariate implies a specific
form of inhomogeneity such that equality of covariates implies equality of response
distributions: xi = xj implies Yi ∼ Yj . In practice, approximate equality of x-values
also implies approximate equality of distributions. Likewise, a relationship is a
function on pairs of units such that R(i, i′) = R(j, j′) implies (Yi, Yi′) ∼ (Yj , Yj′) for
distinct pairs i 6= i′, j 6= j′, provided that the two pairs also have the same covariate
values: (xi, xi′) = (xj , xj′). Geographic distance and genetic distance are two
examples of symmetric relationships. The overarching principle is that differences
in distribution, marginal or joint, must be associated with specific inhomogeneities
in the experimental material.
The status of certain variables in specific survival studies may appear genuinely
unclear. The conventional rationalization, in which certain variables used for predic-
tion are notionally ‘fixed’ or non-random and treated as covariates, is not especially
helpful. Consider, for example, marital status as one variable in a geriatric study
in which the goal is to study both quality of life and survival time. However it is
defined, quality of life is a multi-dimensional response, a combination of mobility,
independence, optimism, happiness, family support, and so forth. Marital status is
a temporal variable known to be associated with survival and with quality of life;
one goal may be to predict survival given marital status, or even to recommend
a change of status in an effort to improve the quality of life. Another example of
a similar type is air quality and its relation to the frequency and severity of asth-
matic attacks (Laird, 1996). Should such a variable be regarded as a covariate or as
one component of the response? For survival studies, and for longitudinal studies
generally, the answer is clear: every time-evolving variable is necessarily part of the
response process.
By definition, a temporal variable x is a function defined for every t ≥ 0. A
temporal variable is a covariate if it is also a function on the units, meaning that
the entire function is determined and recorded at baseline. Usually this means
that x is constant in time, but there are exceptions such as patient age: see also
section 2.5. Marital status and air quality, however, are not only temporal variables,
but variables whose trajectories evolve over real time; neither is available as a
covariate at baseline.
With marital status as a component of the survival process, the joint distribution
may be used to predict the survival time beyond t of an individual whose marital
history and other health-status measurements at certain times prior to t are given.
For that purpose, it is necessary to compute the conditional distribution of T, or
more generally of Y, given the observed history Ht at the finite set of appointments
prior to t. For such calculations to make mathematical sense, marital status must
be a random variable, a function of the process Y. Thus, the statement ‘marital
status is a random process’ is not to be construed as a sociological statement about
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the fragility of marriage or the nature of human relations; it is merely a mathe-
matical assertion to the effect that probabilistic prediction is not possible without
the requisite mathematical structure of σ-fields Ht ⊂ Ht′ for t ≤ t′ and probability
distributions.
2.5 Treatment
A treatment arm is a protocol specifying the therapy, drug type, dose level, manner
of ingestion, and even the next appointment date, as a function of current medi-
cal circumstances and health history. Examples of simple treatment arms include
one-time surgical procedures with follow-up care as appropriate, or a fixed pharma-
ceutical regimen such as 10 mg. Lipitor per day, or regular attendance at weekly
counselling sessions. In general, a treatment arm may specify a range of different
actions depending on current health and past history, so two individuals on the
same arm need not be experiencing the same medical therapy at the same time.
Treatment refers to a scheduled intervention or series of interventions in which, at
certain pre-specified times following recruitment, patient i is switched from one arm
to another. Thus, ai(t) is the treatment arm scheduled for patient i at time t ≥ 0.
In general, but crucially for revival models, a null level is needed for t ≤ 0, including
the baseline t = 0. The entire temporal trajectory ai(t) for t > 0 is determined by
randomization and recorded at baseline. It does not evolve over real time in response
to the doctor’s orders or the patient’s perceived needs, so it is not a time-evolving
variable. Ordinarily, the random variables a1(·), . . . , an(·) are not independent. In
the sense that it is recorded at baseline, ai(·) is a covariate; in the sense that it is
a temporal function, it is a time-dependent covariate.
Apart from crossover trials, the distribution of a(·) is such that a switch of
treatment arms occurs only once, and then only immediately after recruitment.
Nonetheless, more general formulation is retained to underline the fact that treat-
ment is a scheduled intervention such that ai(t) 6= ai(0), and thus not constant in
time. Unlike the survival process, the treatment schedule does not evolve randomly
in real time.
Let a¯i(s) = ai(Ti − s) be the treatment arm expressed in revival time, so that,
in the standard setting, a¯i(s) is null for s ≥ Ti. While ai(·) is a covariate, a¯i(·)
is not. It is automatic that that Z ⊥ T | a¯, because T is a function of a¯. In the
case of treatment, however, the crucial assumption is lack of interference, i.e., the
treatment assigned to one individual has no effect on the response distribution for
other individuals, and the treatment protocol at one point in time has no effect
on the response distribution at other times. For the latter, the statement is as
follows. For each finite subset s ⊂ <+, the conditional distribution of Z[s] given
the treatment schedule and survival time depends only on the treatment arms a¯[s]
prevailing at the scheduled times, i.e.,
Z[s] ⊥ a¯ | a¯[s].
For crossover trials in particular, this is a strong assumption denying carry-over
effects from earlier treatments or later treatments. It implies in particular that
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Z(s) ⊥ T | a¯(s), which is primarily a statement about the one-dimensional marginal
distributions. Note, however, that the interference assumption is relatively benign
if ai(t) is constant for t > 0, as is ordinarily the case.
It is common practice in epidemiological work for certain time-evolving variables
to be handled as covariates, as if the entire trajectory were recorded at baseline.
This approach is perfectly reasonable for an external variable such as air quality
in an asthma study where lack of cross-temporal interference might be defensible.
It has the advantage of leading to simple well-developed procedures for effect esti-
mation using marginal moments (Zeger and Liang, 1986; Zeger, Liang and Albert,
1988; Laird, 1996; Diggle, Heagerty, Liang and Zeger, 2002). The same approach is
less convincing for an evolving variable such as marital status in a survival study, be-
cause the entire trajectory—suitably coded for t > Ti—would often contain enough
information to determine the survival time.
3 Survival prediction
3.1 Conditional distribution
Consider the simplest model in which observations for distinct patients are indepen-
dent and identically distributed. To simplify matters further, problems related to
parameter estimation are set aside. In other words, the survival time is distributed
according to F , and the revival processes given T = t is distributed asG(· | t). Given
the joint distribution, we are free to compute whatever conditional or marginal dis-
tribution is needed to address the inferential target.
We consider here the question of how the partial trajectory of Y affects the
subsequent survival prognosis. The problem is to predict the survival time of an
individual given the survival process Y [t(k)] at the first k appointments t(k) = (t0 <
· · · < tk−1).
For positive real numbers s = (s1 > · · · > sk), let gk(z; s | t) be the conditional
joint density given T = t of the health-status values
Z[s] = (Z(s1), . . . , Z(sk)) = (Y (T − s1), . . . , Y (T − sk)).
Under the conditional independence assumption (1), which implies non-preferential
appointment dates in the sense of Diggle, Menezes and Su (2010), the joint density
of (T, t(k), Y [t(k)]) at (t, t(k), y) is a product of three factors:
f(t)×
∏
j<k
p(tj , yj | Hj , T = t)
= f(t)×
∏
j<k
p(yj | Hj , T = t)×
∏
j<k
p(tj | Hj , T = t)
= f(t)× gk(y; t− t(k) | t)×
∏
j<k
p(tj | Hj , T = t), (2)
where f = F ′ is the survival density, and Hj is the observed history (t(j), Y [t(j)])
at time tj−1. Without further assumptions, all three factors depend on t, meaning
that all three components are informative for survival prediction.
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In all subsequent discussion concerning prediction, it is assumed that the ap-
pointment schedule is uninformative for prediction in the sense that
p(tk | Hk, T = t) = p(tk | Hk, T =∞) (3)
for tk−1 < tk < t. This means that the next appointment is scheduled as if T =∞,
but it is not recorded unless tk < T . With this assumption, the third factor in (2)
is constant in t and can be ignored. In other words, the distribution of the time
to the next scheduled appointment may depend on the patient’s medical history,
but is independent of the patient’s subsequent survival. Ordinarily, the scheduled
appointment is included as a component of the patient’s record only if it occurs in
[0, T ) while the patient lives, implying that the partial appointment schedule t(k)
is uninformative for subsequent survival. In particular, an administrative schedule
is uninformative.
Figure 1: Conditional density of survival time for various values of β.
A simple numerical example illustrates the idea. Suppose T is exponentially
distributed with mean 10 years, and the revival process for s > 0 is a real-valued
Gaussian process with mean E(Z(s)) = βs/(1 + s) and covariance function δss′ +
exp(−|s− s′|) for s, s′ > 0. The observed health-status values at t = (0, 1, 2, 3) are
y = (6.0, 4.5, 5.4, 4.0).
For β = 0, the conditional density is such that T−3 is exponential with mean 10;
the conditional density is shown for various values 0 ≤ β ≤ 2 in the left panel of
Fig. 1, and for 4 ≤ β ≤ 8 on the right. Evidently, the conditional distribution
depends on both the observed outcomes and on the model parameters: the median
residual lifetime is not monotone in β. In applications where β is estimated with ap-
preciable uncertainty, the predictive distribution is a weighted convex combination
of the densities illustrated.
The conditional survival distribution given Y [t(k)] depends not only on the cur-
rent or most recent value, but on the entire vector. In particular, the conditional
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distribution does not have the structure of a regression model in which the longitu-
dinal variable enters as a time-dependent covariate without temporal interference.
Thus, on the assumption that the joint model is adequate, issues related to covariate
confounding do not arise.
3.2 A simple Gaussian revival process
Under assumptions (1) and (3), the ratio of the conditional survival density at t
to the marginal density is proportional to the factor gk(y; t−t(k)), in which y, t(k) are
fixed, and t the variable. This modification factor—the Radon-Nikodym derivative—
depends only on the revival process, not on the distribution of survival times. On
a purely mathematical level, it is precisely the likelihood function in the statistical
model for the k-dimensional variable Y [t(k)] whose conditional distribution given
T = t is Gk(y; t− t(k) | t) for some value of the temporal offset parameter t > tk−1.
Although not realistic for most applications, suppose that G is Gaussian with
mean µ(s) = α + βs independent of t and linear in reverse time, and covariance
function cov(Z(s), Z(s′) | t) = K(|s− s′|). Then the log density ratio factor
log gk(y; t− t(k) | t) = const− 12 (y − µ[t− t])′K−1(y − µ[t− t]),
is quadratic in t for t > tk−1. After substituting α+β(t− t) for the mean function,
and expressing the log density ratio as a quadratic in t, it can be seen that the
predictive density ratio at t > tk−1 is the density at βt of the Gaussian distribution
with mean
−α+ 1′K−1(y + βt(k))/(1′K−11) = y¯ − α+ βt¯
and variance 1/(1′K−11), where K has components K(ti − tj). Ignoring the de-
pendence on the data that comes from parameter estimation, the dependence of
the predictive density ratio on the data for one patient comes through the weighted
averages
y¯ = 1′K−1y/(1′K−11), t¯ = 1′K−1t/(1′K−11) (4)
for this particular individual.
3.3 Exchangeable Gaussian revival process
In a more natural Gaussian model, the revival processes for distinct patients are
exchangeable but not necessarily independent. Revival models of this sort have
much in common with growth-curve models (Lee, 1988, 1991) in which Zi(s) =
µ(s) +η0(s) +ηi(s) is a sum of two independent zero-mean Gaussian processes, and
the mean function µ(s) is constant across individuals. Usually the common devi-
ation η0(·) is moderately smooth but not stationary, perhaps fractional Brownian
motion with η0(0) = 0. The idiosyncratic deviations are independent and identi-
cally distributed and they incorporate measurement error, so ηi(·) is ordinarily the
sum of a continuous process and white noise. Thus, the Gaussian process is defined
by
E(Zis) = µ(s) (5)
cov(Zis, Zi′s′) =K0(s, s
′) + δii′K1(s, s′) + σ2δii′δss′
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for some suitable covariance functions K0,K1, each of which can be expected to have
a variance or volatility parameter and a range parameter. In the case of fractional
Brownian motion, for example, K(s, t) ∝ sν + tν − |s − t|ν for some 0 < ν < 2,
which governs the degree of smoothness of the random function.
For a new patient such that Y [t(k)] = y, the conditional survival density pr(T ∈
dt | data) given the data, including the outcomes for the new patient, is computed in
the same way as above. The second factor in (2) is the density at the observed out-
comes of the Gaussian joint distribution whose means and covariances are specified
above. This involves all n+ 1 patients.
3.4 Illustration by simulation
Figure 2 shows simulated data for 200 patients whose survival times are independent
exponential with mean five years. While the patient lives, annual appointments are
kept with probability 5/(5 + t), so appointment schedules in the simulation are
not entirely regular. Health status is a real-valued Gaussian process with mean
E(Z(s)) = 10 + 10s/(10 + s) in reverse time, and covariances
cov(Z(s), Z(s′)) = (1 + exp(−|s− s′|/5) + δss′)/2
for s, s′ > 0, so there is an additive patient-specific effect in addition to temporal
correlation. Values for distinct patients are independent and identically distributed.
This distribution is such that health-status plots in reverse time aligned by failure
show a stronger temporal trend than plots drawn in the conventional way. The
state of health is determined more by time remaining before failure than time since
recruitment. These trends could be accentuated by connecting successive dots for
each individual, as in Fig. 2 of Sweeting and Thompson (2011), but this has not
been done in Fig. 2.
Figure 2: Simulated health status sequences aligned by recruitment time (left) and
the same sequences aligned by failure time (right)
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Since the survival times are exponential with mean five, independent of covari-
ates and treatment, the root mean squared prediction error using covariates only
is five years. For fixed k ≥ 2, and a patient having at least k appointments, the
conditional survival distribution given the first k health-status values has a stan-
dard deviation depending on the observed configuration, but the average standard
deviation is about 1.4 years, and the root mean squared prediction error is about
1.7 years. Using only the appointment schedule as a lower bound on the survival
time, the root mean squared prediction error is 3.9 years. For this setting, the lon-
gitudinal variable is a reasonably effective predictor of survival, and the prediction
error is almost independent of k in the range 2–5. This summary does not tell the
full story because certain y-configurations lead to very precise predictions whereas
others lead to predictive distributions whose standard deviation exceeds five years.
The parameter settings used in this simulation may not be entirely representative
of the range of behaviours of the conditional survival distribution given Y [t]. If the
ratio of the between-patient to within-patient variance components is increased, the
average variance of the conditional survival distribution decreases noticeably with
k. For such settings, prediction using the entire health history is more effective than
prediction using the most recent value.
4 Parameter estimation
4.1 Likelihood factorization
The joint density for the observations in a revival model factors into two parts, one
involving only survival times, the other involving only the revival process. More
generally, the second factor is the conditional distribution of the revival process
given T = t, so both factors depend on t. Although both factors may involve the
same covariates and treatment indicators, the parameters in the two parts are as-
sumed to be unrelated, i.e., variation independent. Thus the likelihood also factors,
the first factor involving only survival parameters such as hazard modifiers associ-
ated with treatment and covariates, the second factor involving only health-status
parameters such as temporal trends and temporal correlations. In other words, the
two factors can be considered separately, either for maximum likelihood estimation
or for Bayesian operations.
This approach is related to pattern-mixture modeling as discussed in Fieuws
et al. (2008) in which the joint density pr(T, Y ) is factorized as pr(Y | T ) pr(T ).
Therefore the revival model can be viewed as a particular choice of pattern-mixture
model. Initial contributions to the pattern-mixture approach include Little (1993)
in the context of longitudinal clinical trials with dropout.
4.1.1 Survival distribution specification
The first stage in parameter estimation is to estimate the survival distribution F
together with treatment and covariate effects if needed. Whether the model for
survival times is finite-dimensional or infinite-dimensional, this step is particularly
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simple because the first factor involves only the survival times and survival distribu-
tion. The standard assumption of independent survival times for distinct patients
simplifies the problem even further. Exponential, gamma and Weibull models are
all feasible, with treatment effects included in the standard way.
For the Cox proportional-hazards model, the situation is a little more com-
plicated. First, the survival time is finite with probability one if and only if the
integrated hazard Λ(<+) = ∫∞
0
λ(t) dt is infinite, which is not satisfied at all pa-
rameter points in the model. Second, the partial likelihood function depends only
on baseline hazard values λ(t) in the range 0 ≤ t ≤ Tmax, where Tmax is the max-
imum observed survival time, censored or uncensored. Thus, the likelihood does
not have a unique maximum, but every maximum has the property that λˆ(t) = 0
for all 0 ≤ t ≤ Tmax except for failure times, at which λˆ has a discrete atom. By
common convention (Kaplan and Meier 1958; Cox 1972, §8) λˆ(t) = 0 for t > Tmax,
but this choice is not dictated by the likelihood function. Since the revival model
requires survival times to be finite with probability one, it is essential to restrict the
space of hazards to those having an infinite integral, which rules out the standard
convention for λˆ. Equivariance under monotone temporal transformation points to
a mathematically natural choice λˆ(t) =∞ for t > Tmax; a less pessimistic option is
to use a finite non-zero constant such as
λˆ(t) =
total number of failures
total person time at risk
(6)
for t > Tmax. Both of these maximize the proportional-hazards likelihood function—
restricted or unrestricted—and either one may be used in the revival model.
A less arbitrary alternative is to consider the set of neutral to the right processes
(Kalbfleisch (1978), Clayton (1991), and Hjort (1990)). Such processes are ex-
changeable survival process constructed by generating survival times conditionally
independent and identically distributed via a completely independent hazard mea-
sure, i.e. the cumulative conditional hazard is a Le´vy process. These automatically
satisfy the property that the survival time is finite with probability one. Dempsey &
McCullagh (2015) show a correspondence with Markov survival processes, studying
in particular the harmonic process for which the conditional distributions have a
close affinity with the Kaplan-Meier estimator. For exchangeable survival times, the
harmonic process is defined by two non-negative parameters, (ρ, ν). The marginal
survival time is exponential with rate ν ·(ψ(1+ρ)−ψ(ρ)) where ψ is the derivative of
the log gamma function. Given unique survival times T1 < . . . < Tk the conditional
hazard is the product of a continuous and discrete component. The continuous
component is
H(t) =
∑
i:Ti≤T
ν
Ti − Ti−1
R](Ti−1) + ρ
+ ν
T − Tj
R](Tj) + ρ
,
where R](t) is the number of at risk individuals at time t−. The sum runs over
event times, censored or failure, such that Ti ≤ T , and Tj is the last such event.
The discrete component is a product over failure times∏
j:Tj≤t
(∆djζ)(rj + 1)
(∆djζ)(rj)
=
∏
j:Tj≤t
rj + ρ
rj + dj + ρ
. (7)
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The hazard rate for t > Tmax is constant, λ = ν/ρ. Given ρ, the maximum likelihood
estimate for λ is [
ρ
k
∫ ∞
0
(ψ(ρ+R](t))− ψ(ρ))dt
]−1
As ρ tends to zero, the estimate tends to k/Tmax, while for ρ → ∞, the estimate
approaches equation (6). Appendix E derives the estimators as ρ tends to zero when
the marginal survival times are assumed to be distributed Weibull.
The harmonic process has both a simple form for the joint density and is easy to
generate sequentially. Moreover, it is the only non-trivial Markov survival process
with predictive distributions that are weakly continuous as a function of the initial
configuration. The only exception is the iid process, which arises as the limit ρ→∞
in which tied failures occur with probability zero. Given the above, it is a natural
choice when working with the revival process.
4.1.2 Revival process specification
The second stage, which is to estimate the parameters in the revival process, is
also straightforward, but only if all records are complete with no censoring. Serial
dependence is inevitable in a temporal process, and there may also be independent
persistent idiosyncratic effects associated with each patient, either additive or mul-
tiplicative. Gaussian revival models are particularly attractive for continuous health
measurements because such effects are easily accommodated with block factors for
patients and temporal covariance functions such as those included in the simulation
in Fig. 2.
Thus the second stage involves mainly the estimation of variance components
and range parameters in an additive Gaussian model. One slight complication
is that the revival process is not expected to be stationary, which is a relevant
consideration in the selection of covariance functions likely to be useful. Another
complication is that the health status may be vector-valued, Y (t) ∈ <q, so there
are also covariance component matrices to be estimated. If the covariance function
is separable, i.e.
cov(Zir(s), Zir′(s
′)) = Σr,r′K(s, s′)
for some q × q matrix Σ, maximum-likelihood estimation is straightforward. But
separability is a strong assumption implying that temporal correlations for all health
variables have the same pattern, including the same decay rate, which may not be
an adequate approximation. Nevertheless, this may be a reasonable starting point.
The second stage requires all health records to be aligned at their termini. Ac-
cordingly, a record that is right censored (Ti > ci) cannot be properly aligned. If the
complete records are sufficiently numerous, the simplest option is to ignore censored
records in the second stage, on the grounds that the estimating equations based on
complete records remain unbiased. This conclusion follows from the fact that the
second factor is the conditional distribution given survival time. Thus, provided
that the censoring mechanism is a selection based on patient survival time, the es-
timating equations derived from complete records are unbiased. The inclusion of
censored records is thus more a matter of statistical efficiency than bias, and the
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information gained from incomplete records may be disappointing in view of the
additional effort required.
4.2 Incomplete records
If we choose to include in the likelihood the record for a patient censored at c > 0, we
need the joint probability of the event T > c, the density of the subset tc = t∩ [0, c],
and the outcome Y [tc] at y. On the assumption that censoring is uninformative,
i.e., that the distribution of the subsequent survival time for a patient censored at
time c is the same as the conditional distribution given T > c for an uncensored
patient, the joint density is∫
t≥c
f(t) p(tc | t) g(y; t− tc) dt
on the space of finite-length records. Assumption (3) implies that the second factor,
the density of the appointment dates in [0, c] for a patient surviving to time t > c,
does not depend on the subsequent survival time t − c, in which case it may be
extracted from the integral. It is also reasonable to assume that the distribution
of appointment schedules is known, for example if appointments are scheduled ad-
ministratively at regular intervals, in which case the second factor may also be
discarded. Since the survival probability 1−F (c) is included in the first-stage like-
lihood, the additional likelihood factor needed in the analysis of the revival model
is
1
1− F (c)
∫
t>c
f(t) g(y; t− tc) dt,
in which tc may regarded as a fixed subset of [0, c]. Unfortunately, the integral
involves both the survival density f(t) = F ′(t) and the density of the revival process,
so the full likelihood no longer factors. For an approximate solution, f may be
replaced with the estimate obtained from the first-stage analysis of survival times,
and if fˆ is purely atomic, the integral is converted to a finite sum.
For an incomplete record, the component of the derivative of the log-likelihood
with respect to revival parameters, ψ, associated with the censored record (Y [t(k)],
t(k), c) is
Eψ,θ
[
d log g(y; t− tc;ψ)
dψ
| (Y [tc], tc), T > c
]
where θ denotes the survival parameters assumed common to both. This is the
expected value of the score given the observed censored record and censoring time.
Treating the survival time as missing data, a simple imputation method is proposed
for approximate maximum likelihood estimation. First, impute survival times, T ′,
using the conditional survival distribution
f
(
T | (Y [tc], tc), T > c; ψˆu, θˆ
)
∝ f(T ; θˆ) g(Y [tc];T − tc, ψˆu) · 1[T > c]
where ψˆu is the maximum likelihood estimate of the revival parameters for uncen-
sored records, and θˆ the maximum likelihood estimate of the survival parameters
using both uncensored and censored records.
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In this case the log-likehood component associated with the imputed, uncensored
record is given by
log g(y;T ′ − tc;ψ) + log f(T ′; θ),
so parameter estimation after imputation is again straightforward. Imputation per-
formed multiple times creates imputed estimates {ψˆ(I)1 , . . . , ψˆ(I)M } with standard
errors {s(I)1 , . . . , s(I)M }. These can then be averaged to get a complete-data estimate,
ψˆ = 1M
∑M
m=1 ψ
(I)
m . A variance estimate, Vψ reflects variation within and between
imputations:
Vψ = W +
(
1 +
1
m
)
B
where W = 1M
∑
s2m and B =
1
M−1
∑M
m=1
(
ψˆm − ψˆ
)2
. Let ψˆ
(c)
imp denote the esti-
mate for the censored records under imputation of the survival times.
Given maximum likelihood estimates, ψˆ(c) and ψˆ(u), and corresponding standard
errors, Vˆ c and Vˆ u, the following statistic is proposed for testing whether censored
records are consistent with uncensored records:
Ti =
ψˆ
(c)
i − ψˆ(u)i√
(Vˆ ci )
2 + (Vˆ ui )
2
(8)
The denominator is the estimated variance of the difference under independence of
the patients’ revival processes. While equation (8) can be used, when the survival
times are imputed the estimates, ψˆ(u) and ψˆ
(c)
imp, are positively correlated as the
imputed survival times use the maximum likelihood estimate for uncensored records,
resulting in a conservative test statistic. Appendix A discusses an appropriate
modification of the test statistic in this case.
Exact likelihood analysis for incomplete records is technically more involved
and is therefore omitted; however, the imputed estimates provide a first step in this
direction. The situation is considerably more complicated if, as in section 3.3, the
revival processes for distinct patients are not independent.
4.3 Treatment effect: definition and estimation
We consider here only the simplest sort of revival model for the effect of treatment
on patient health, ignoring entirely its effect on survival time. Health status in the
revival process is assumed to be Gaussian, independent for distinct patients, and
the treatment is assumed to have an effect only on the mean of the process, not on
its variance or covariance. Consider two patients, one in each treatment arm,
ai(t) = a¯i(Ti − t) = 1, aj(t) = a¯j(Tj − t) = 0
such that xi = xj . If Z is independent of T , then the random variable Zi(s)−Zj(s)
is distributed independently of the pair Ti, Tj . By definition, the treatment effect
as defined by the revival model is the difference of means
τ10(s) = E(Zi(s))− E(Zj(s)) = E(Yi(Ti − s))− E(Yj(Tj − s))
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at revival time s. This is not directly comparable with either of the the conventional
definitions
γ10(t) = E(Yi(t)− E(Yj(t)) or γ′10(t) = E(Yi(t)− E(Yj(t) | Ti, Tj > t)
in which the distributions are compared at a fixed time following recruitment. The
expectation in a survival study—that healthy individuals tend to live longer than
the frail—implies that E(Y (t) | T ) must depend on the time remaining to failure.
In that case, the conventional treatment definition γ′10(t) depends explicitly on the
difference between the two survival times. In other words, it does not disentangle
the effect of treatment on patient health from its effect on survival time.
If Z is not independent of T but the dependence is additive, the difference of
means at revival time s
E(Zi(s) | T )− E(Zj(s) | T ) = τ10(s) + γ(Ti)− γ(Tj)
contains both a treatment effect and an effect due to the difference in survival
times. In other words, the fact that Z and T are not independent does not neces-
sarily complicate the interpretation of treatment effects. By contrast with standard
practice in the analysis of randomized trials with longitudinal responses, (Fitzmau-
rice, Laird and Ware 2011, section 5.6), it is most unnatural in this setting to work
with the conditional distribution given the baseline outcomes Yi(0) ≡ Zi(Ti). This
is one reason why the baseline response should be regarded as an integral part of
the outcome sequence, not as a covariate. Exchangeability implies distributional
equality Zi(Ti) ∼ Zj(Tj) for individuals having the same covariate values, but it
does not imply equality of conditional distributions given T . On the presump-
tion that treatment assignment is independent of baseline response values, we also
have Zi(Ti) ∼ Zj(Tj) conditionally on treatment, whether or not ai, aj are equal.
Consequently, in order to satisfy the exchangeability assumption, it is necessary to
introduce a null, pre-randomization, treatment level, ai(0) = aj(0), common to all
subjects.
4.4 Testing independence of Z and T
It is of interest to test whether the revival process Z is independent of the survival
time T . To do this, it is easy to formulate and fit a specific alternative models in
which the revival process is not independent of the survival time. We consider here
only the simplest design in which all records are complete, there are no covariates
or treatment assignment, observations for distinct patients are independent, and
the revival model is a family of Gaussian process. One way to do this is to replace
(5) with
E(Zi(s) | T ) = µ(s, Ti)
for some suitable family of functions µ(s, T ), leaving the covariances unchanged.
For example, if x denotes patient age at recruitment, the revival mean might be
modeled as
E(Zi(s) | T ) = µ(s) + β1xi + β2Ti
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depending additively on patient age and survival time. If β1 = β2, the dependence
is on age at failure rather than age at recruitment. More general models involving
multiplicative interactions between s and Ti may also be considered.
Consider, for instance, the non-linear Gaussian revival model with mean
µ(s) = α+ βs/(γ + s),
which is such that µ(0) = α, µ(∞) = α + β, and µ(γ) = 12 (µ(0) + µ(∞)), so that
γ > 0 is the semi-revival time. Within this family, the revival trajectory for one
patient could be different from that of another, depending on their survival times.
In other words, α, β, γ could depend on T or x + T , either of which is a violation
of the independence assumption. One of the simplest models of this type is the
time-accelerated revival model in which the semi-revival time is inversely related to
survival,
µ(s, T ) = µ0(sT ) = α+ βsT/(γ + sT ).
As a practical matter, it would be more effective to replace γ with γ0 + γ1/T or
exp(γ0 + γ1/T ) to generate a test of independence. Likewise, we could replace α
with α0 + α1Ti, asserting that the outcome sequences for long-lived patients are
elevated by a constant amount at all revival times. Similarly, if β is replaced with
β0 + β1Ti, the the asymptote is elevated in proportion to the additional lifetime.
Any modification of this sort is a violation, so the survival time and the revival
process are not independent. However, the factorization of the likelihood function
remains intact, so the analysis remains relatively straightforward. For example, a
likelihood ratio statistic can be constructed by fitting two nested models to the
revival process, one assuming independence, the other not.
5 A worked example: cirrhosis study
5.1 Prednizone and prothrombin levels
In the period 1962–1969, 532 patients in Copenhagen hospitals with histologi-
cally verified liver cirrhosis were randomly assigned to two treatment arms, con-
trol and prednisone. Only 488 patients for whom the initial biopsy could be
reevaluated using more restrictive criteria were retained, yielding 251 and 237 pa-
tients in the prednisone and placebo groups respectively. Variables recorded at
entry include sex, age, and several histological classifications of the liver biopsy.
Clinical variables were also collected, including information on alcohol consump-
tion, nutritional status, bleeding, and degree of ascites. However, these covariates
were not included in the dataset used here, which was downloaded from the R li-
brary http://cran.r-project.org/web/packages/joineR maintained by Philip-
son Sousa, Diggle, Williamson, Kolamunnage-Dona and Henderson. At the end of
the study period, the mortality rate was 292/488, or approximately 60%.
The focus here is on the prothrombin index, a composite blood coagulation in-
dex related to liver function, measured initially at three-month intervals and subse-
quently at roughly twelve-month intervals. The individual prothrombin trajectories
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Figure 3: Prothrombin mean trajectories aligned by recruitment and by failure
are highly variable, both in forward and in reverse time, which tends to obscure
patterns and trends. In Figure 3a the mean trajectory is plotted against time from
recruitment for two patient groups placebo/prednisone and censored/not censored.
Naturally, only those patients who are still alive are included in the average for that
time. Figure 3b shows the same plots in reverse alignment. While there are certain
similarities in the two plots, the differences in temporal trends are rather striking.
In particular, prothrombin levels in the six months prior to censoring are fairly
stable, which is in marked contrast with levels in the six months prior to failure, as
seen in the lower pair of curves.
Inspection of the graphs for uncensored patients in the right panel of Figure 3
suggests beginning with the simplest revival model in which the sequences for dis-
tinct patients are independent Gaussian with moments
E(Zi(s) | T ) = α+ τa¯i(s) + β0Ti + β1s+ β2 log(s+ δ)
cov(Zi(s), Zj(s
′) | T ) = σ21δijK1(s, s′) + σ22δij + σ23δijδss′ .
The non-linear dependence on s is accommodated by the inclusion of log(s+ δ) in
the mean model with a temporal offset δ, which is equal to one day in all subsequent
calculations. Inclusion of the survival time Ti is suggested by the increasing trend
along the diagonals and sub-diagonals of Table 1. Since the value at recruitment is
included as a response for each series, treatment necessarily has three levels, null,
control and prednisone. The three covariance terms are associated with independent
additive processes, the second for independent and identically distributed patient-
specific constants, and the third for independent and identically distributed white
noise or measurement error. The first covariance term governs the prothrombin
sequences for individual patients, which are assumed to be continuous in time with
covariance function K1(s, s
′) = exp(−|s − s′|/λ) for s, s′ > 0. The temporal range
in all subsequent calculations is set at λˆ = 1.67 years, implying an autocorrelation
of 0.55 at a lag of one year. The implied one-year autocorrelation for the observed
prothrombin sequences is considerably smaller, roughly 0.30, because of the white-
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noise measurement term.
For the initial likelihood calculations that follow, incomplete records are ignored;
only the 1634 measurements for the 292 non-censored patients are used. The fitted
variance components, estimated by maximizing the residual likelihood, are
(σˆ21 , σˆ
2
2 , σˆ
2
3) = (210.0, 206.8, 179.6),
all significantly positive. Using these values to determine the covariance matrix, the
weighted least-squares coefficients in the mean model are shown in Table 3. The
standard error for the prednisone/control contrast is 1.77, somewhat larger than
the standard error for the prednisone/null contrast because the former is a contrast
between patients involving all three variance components, whereas the latter is a
contrast within patients, which is unaffected by the second variance component.
Table 3: Coefficients for revival model
Censored Records Uncensored Records
Covariate Coef. S.E. Ratio Coef. S.E. Ratio
Null Treatment 0.00 - - 0.00 - -
Control 4.13 1.84 2.3 2.41 1.43 1.7
Prednizone 11.56 1.75 6.6 13.55 1.47 9.2
Survival (T ) 2.65 0.39 6.9 1.75 0.47 3.7
Revival (s) −2.78 0.49 −5.7 −2.11 0.47 −4.5
log(s+ δ) 3.74 2.68 1.4 4.66 0.41 11.5
λ 0.164
Various deviations from this initial model may now be investigated. In par-
ticular, it is possible to check whether there is an interaction between treatment
and survival time, i.e., whether the treatment effect for long-term survivors is or
is not the same as the treatment effect for short-term survivors. This comparison
involves two variance-components models having different mean-value subspaces, so
the residual likelihoods are not comparable. For likelihood comparisons, the kernel
subspace must be fixed, and the natural choice is the mean-value subspace for the
null model as described by Welham and Thompson (1997) or as implemented by
Clifford and McCullagh (2006). The likelihood ratio statistic computed in this way
is 0.83 on two degrees of freedom, showing no evidence of interaction. However,
there is appreciable evidence in the data that the treatment effect (prednisone ver-
sus control) decreases as t → T , i.e., as s → 0. The likelihood-ratio statistic for
the treat.s interaction is 3.90 on two degrees of freedom, showing little evidence of
a linear trend, but the value for the treat. log(s) interaction is 8.68, pointing to a
non-linear trend.
We may also check the adequacy of the assumed form for the mean model by
including an additional random deviation, continuous in reverse time, with general-
ized non-stationary covariance function such as K0(s, s
′) = −| log(s+δ)−log(s′+δ)|.
The fitted coefficient is 2.38, and the associated likelihood ratio statistic is 1.2 on
one degree of freedom, showing no significant deviations that are continuous in re-
verse time. Finally, we check whether the sequences for different patients exhibit
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a characteristic pattern or trend associated with time measured from recruitment
by including the generalized Brownian-motion covariance function −|t − t′| in the
covariance model. The fitted variance coefficient is 2.10, and the likelihood ra-
tio statistic is 2.38 on one degree of freedom showing no significant characteristic
patterns that are continuous in time measured from recruitment.
Using the imputation method proposed in section 4.2, revival parameters for cen-
sored records are estimated in order to check consistency with uncensored records.
Assuming the marginal survival time is exponential with rate parameter given by
the first stage maximum likelihood estimate, survival times are imputed. The im-
putation estimates are shown in Table 3. Standard errors of coefficients that do not
depend on the behavior near the origin of the revival times are similar to those for
uncensored records. Not surprisingly, the standard error for log(s + δ) is subtan-
tially higher for censored records. The parameters associated with the survival and
revival times show some deviation across record type, while treatment effects and
the non-linear behavior with respect to the revival time appear consistent. Conclu-
sions appear robust to survival distribution specification as shown in Appendices B
and C, where imputed estimates under both exponential and Weibull specifications
for the above model as well as that including an interaction with treatment are
provided.
A concern may be the parametric specification of the survival time distribution
and whether this limits the method for handling censored records. To address this,
Appendix D shows estimates under the Markov survival process specification when
ρ is sent to zero. The result is a conditional survival distribution equivalent to the
Kaplan-Meier product estimator for t < Tmax. For t ≥ Tmax the hazard function is
the Weibull hazard function. Appendix E finds maximum likelihood estimates for
the survival distribution parameters when the marginal survival times are assumed
Weibull. We see that the estimated conditional distribution is approximately equiv-
alent to assuming the hazard is infinite for all times after Tmax = 13.40. Table 12
and 14 shows the imputed estimates are similar to those under the exponential
specification.
5.2 Effect of prothrombin on prognosis
Over a period of 5 years and one month following recruitment, patient u had eight
appointments with prothrombin values as follows:
tu (days) 0 126 226 392 770 1127 1631 1855
Yu[tu] 49 93 122 120 110 100 72 59
This is in fact the record for patient 402 who was assigned to prednisone and was
subsequently censored at 2661 days. As determined on day 1855, the survival prog-
nosis for this patient depends on preceding sequence of measurements. Relative to
the unconditional survival density for a patient on the prednisone arm, the condi-
tional survival density at time t > max(tu) is modified multiplicatively by a factor
proportional to the joint conditional density of the random variable Zu[t − tu] at
the observed point yu given Tu = t and the data observed for all other patients.
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For the model described in the preceding section—in which the records for dis-
tinct patients are independent—this factor is particularly simple. The conditional
distribution of Zu[t − tu] given T = t has a mean vector µ depending linearly on
t− tu and log(t− tu + δ), and a covariance matrix Σ that is constant in t. The log
density at yu is a quadratic form
h(t, yu) = const− (yu − µ)′Σ−1(yu − µ)/2
depending on t only through µ. This estimated factor is shown in Fig. 4a for three
versions of the record in which the final prothrombin value is 59, 69 or 79.
Figure 4: Three versions of the record for patient 402: log modification factors for
the predictive survival density (left panel) and hazard functions (right panel).
It may be helpful to express the effect of the observed prednisone record on
the conditional survival distribution through its effect on the hazard function at
times t > max(tu) rather than its effect on the conditional survival density. Sup-
pose, therefore, that the unconditional survival time for a patient on the prednisone
arm, is exponential with mean 5 years, so that the unconditional hazard function is
constant. What is the conditional hazard at time t > max(tu) given the prothrom-
bin sequence for patient u, with no further measurements made in the interval
(max(tu), t) other than survival? The conditional hazard functions for the subse-
quent two-year interval 5 < t < 7 are shown in Fig. 4b for the same three versions
of the prothrombin record. It is evident from these plots that the conditional haz-
ard for the real patient is substantially elevated following the last measurement,
but the effect is transient and does not persist for the duration of a typical inter-
appointment interval of one year. If the final value were 79 instead of 59, the hazard
function is almost constant, initially increasing and subsequently reverting to the
long-term value, which is slightly larger than the unconditional hazard.
The preceding analysis indicates that it may be misleading to treat the ob-
served health sequence as a time-dependent covariate in the proportional-hazards
model. At any one failure time t measured from recruitment, some of the health
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measurements are recent and fresh, while others are likely to be up to one year
old. Figure 4b shows that stale measurements may have negligible prognostic value
compared with fresh measurements. The predictive revival model automatically
takes into account the time that has passed since the last appointment, so that
stale values are discounted appropriately.
5.3 Review of assumptions
The conditional independence assumption (1) does not require appointments to be
scheduled administratively, nor does it forbid patient-initiated appointments. Con-
sider two patients i, j at time s prior to failure, having similar prior appointment
schedules and similar health values. Assumption (1) states that the conditional
appointment-initiation intensity given the observed health record and subsequent
survival time does not depend on subsequent health values. In other words, con-
ditional independence implies that patients i, j are equally likely to initiate an ap-
pointment at time s; it is also assumed implicitly that they do so independently.
The evidence presented in section 2.2, and in Liestøl and Andersen (2002) shows
clearly that the rate of patient-initiated appointments increases in the last few
months of life. It is certainly possible that patient behaviour in this instance vi-
olates the conditional independence assumption, but the evidence presented does
not directly address the matter. All in all, assumption (1) seems unavoidable and
relatively benign.
The non-informative assumption (3) is much stronger than (1). It implies that
appointments are scheduled as if the patient will live indefinitely, which is clearly
contradicted by the evidence in this example. We now examine the consequences
of failure of (3), retaining (1).
Assumption (1) implies that the sampling is non-preferential in the sense of
Diggle, Menezes and Su (2010), which means that the second factor in (2) is the
same as if the appointment dates had been fixed by design. Consequently, the
likelihood calculations in section 4 are unaffected by the failure of (3).
If the appointment for patient u on day 1855 were self-initiated in such a way
that the last factor in (2) depends on subsequent survival, it would be technically
incorrect to omit that factor in prognosis calculations. However, if it were known
that all appointments for patient u were on schedule, the possibility of a dependence
on subsequent survival is eliminated, and the prognosis calculations for this patient
is technically correct even if the behaviour of other patients violates (3).
6 Summary
The paper examines the problem of model formulation for health sequences, whose
defining characteristic is that the state space contains an absorbing value. Each
health sequence is terminated ultimately by death, which is not equivalent to ran-
dom restriction or censoring because subsequent values are known. Typically, se-
quence length and sequence values are not independent.
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The principal suggestion is that it may be more natural in some circumstances
to align health sequences by failure time than by age or by recruitment date. The
following list describes various statistical implications of realignment.
1. The health sequence is regarded as a random process in its own right, not as
a time-dependent covariate governing survival.
2. To a substantial extent, the model for survival time is decoupled from the
revival model for the behaviour of the health sequence in reverse time.
3. Realignment implies that value Yi(0) at recruitment must not be treated as
a covariate, but as an integral part of the response sequence. If they were
available, values prior to recruitment could also be used.
4. The definition of a treatment effect is not the usual one because the natural
way to compare the records for two individuals is not at a fixed time following
recruitment, but at a fixed revival time. The treatment value need not be
constant in revival time.
5. The predictive value of a partial health sequence for subsequent survival
emerges naturally from the joint survival-revival distribution. In particular,
the conditional hazard given the finite sequence of earlier values is typically
not constant during the subsequent inter-appointment period.
6. Records cannot be aligned until the patient dies, which means that the revival
process is not observable component-wise until T is known. As a result, the
likelihood analysis for incomplete records is technically more complicated.
This aspect needs further development.
7. The omission of incomplete records from the revival likelihood does not lead to
bias in estimation, but it does lead to inefficiency, which could be substantial
if the majority of records are incomplete.
8. The principal assumption, that appointment dates be uninformative for sub-
sequent survival, does not affect likelihood calculations, but it does affect
prognosis calculations for individual patients. For that reason, it is advisable
to label all appointments as scheduled or unscheduled.
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A Modification of test statistic
If the censored records are consistent with the uncensored records then given ψˆ(u)
the imputed parameter is approximately normal
ψˆ
(I)
j | ψˆ(u) ∼a N
(
ψˆ(u), I
(
ψˆ(u)
))
where I
(
ψˆ(u)
)
= XTj Σ
−1
j Xj where the covariate matrix, Xj , and covariance matrix,
Σj , are computed given the imputed survival time, Tj , at the parameter value ψˆ
(u).
By the law of total variance,
varθ
(
ψˆ
(c)
imp
)
=E
[
var
(
ψˆ
(c)
imp | ψˆ(u)
)]
+ var
(
E
[
ψˆ
(c)
imp | ψˆ(u)
])
=Eθ
[
XT(c)Σ
−1
(c)X(c) | ψˆ(u)
]
+XT(u)Σ
−1
(u)X(u)
where X(u) and X(c) are the covariates for all uncensored and censored records
respectively, and θ is the set of survival parameters. The law of total covariance
implies the covariance is XT(u)Σ
−1
(u)X(u). This implies that
var
(
ψˆ(u) − ψˆ(c)imp
)
= Eθ
[
XT(c)Σ
−1
(c)X(c) | ψˆ(u)
]
≈W
That is, the variance can be approximated from the standard errors of the imputed
estimates. Therefore for the imputed estimates, equation (8) is altered to
T ?i =
(
ψˆ
(c)
imp − ψˆ(u)
)
i√
Wii
for the ith coordinate of the parameter vector. Appendices B and C show the test
statistic using this variant.
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B Estimates: marginal exponential survival
Table 4: Coefficients for revival model : no interaction
Censored records Uncensored records
Covariate Coef. S.E. Ratio Coef. S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control 4.13 1.84 2.3 2.41 1.43 1.7 0.94
Prednizone 11.56 1.75 6.6 13.55 1.47 9.2 −1.14
Survival (T ) 2.65 0.39 6.9 1.75 0.47 3.7 2.79
Revival (s) −2.78 0.49 −5.7 −2.11 0.47 −4.5 −1.72
log(s+ δ) 3.74 2.68 1.4 4.66 0.41 11.5 −0.46
λ 0.164
Table 5: Variance components
Censored records Uncensored records
Coefficient S.E. Coefficient S.E.
AR1 σ21 166.27 29.79 209.95 29.54
Patient σ22 155.84 31.02 206.82 34.48
White Noise σ23 223.69 17.30 179.59 12.90
Table 6: Coefficients for revival model : with interaction
Censored records Uncensored records
Covariate Coef. S.E. Ratio Coef.* S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control −1.49 6.41 −0.23 1.79 1.51 1.19 −0.63
Prednizone 1.74 5.07 0.34 13.55 1.57 8.65 −2.50
Survival (T ) 2.75 0.38 7.25 1.78 0.48 3.70 2.98
Revival (s) −2.73 0.49 −5.57 −2.06 0.49 −4.24 −1.70
log(s+ δ) 0.17 3.97 0.04 4.07 1.06 3.85 −1.42
log(s+ δ):Control 2.46 2.86 0.86 −0.31 0.94 −0.33 1.24
log(s+ δ):Prednizone 4.65 2.25 2.07 1.39 0.92 1.51 1.57
Table 7: Variance components for revival model : with interaction
Censored records Uncensored records
Coefficient S.E. Coefficient S.E.
AR1 σ21 164.02 29.60 212.31 29.53
Patient σ22 155.57 31.54 206.51 34.51
White Noise σ23 223.23 17.27 176.96 12.79
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C Estimates : marginal Weibull survival
Table 8: Coefficients for revival model : no interaction
Censored records Uncensored records
Covariate Coef. S.E. Ratio Coef. S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control 4.11 1.84 2.24 2.41 1.43 1.69 0.93
Prednizone 11.56 1.75 6.61 13.55 1.47 9.21 −1.14
Survival (T ) 2.74 0.43 6.39 1.75 0.47 3.70 2.89
Revival (s) −2.77 0.52 −5.73 −2.11 0.47 −4.51 −1.54
log(s+ δ) 3.29 2.69 1.22 4.66 0.41 11.47 −0.65
λ 0.159
k 1.233
Table 9: Variance components for revival model : no interaction
Censored records Uncensored records
Coefficient S.E. Coefficient S.E.
AR1 σ21 166.61 29.80 209.95 29.54
Patient σ22 156.17 31.14 206.82 34.48
White Noise σ23 223.70 17.30 179.59 12.90
Table 10: Coefficients for revival model : with interaction
Censored records Uncensored records
Covariate Coef. S.E. Ratio Coef.* S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control −1.97 6.73 −0.29 1.79 1.51 1.19 −0.68
Prednizone 0.48 5.57 0.09 13.55 1.57 8.65 −2.57
Survival (T ) 2.87 0.42 6.81 1.78 0.48 3.70 3.14
Revival (s) −2.68 0.54 −4.94 −2.06 0.49 −4.24 −1.44
log(s+ δ) −1.00 4.47 −0.22 4.07 1.06 3.85 −1.63
log(s+ δ):Control 2.70 3.11 0.87 −0.31 0.94 −0.33 1.23
log(s+ δ):Prednizone 5.41 2.56 2.11 1.39 0.92 1.51 1.73
Table 11: Variance components for revival model : with interaction
Censored records Uncensored records
Coefficient S.E. Coefficient S.E.
AR1 σ21 164.18 29.58 212.31 29.53
Patient σ22 156.22 31.61 206.51 34.51
White Noise σ23 223.25 17.25 176.96 12.79
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D Estimates : adjusted Kaplan-Meier estimates
Table 12: Coefficients for revival model : no interaction
Censored Records Uncensored Records
Covariate Coef. S.E. Ratio Coef. S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control 4.06 1.83 2.22 2.41 1.43 1.69 0.90
Prednizone 11.44 1.75 6.53 13.55 1.47 9.21 −1.21
Survival (T ) 2.86 0.46 6.28 1.75 0.47 3.70 2.71
Revival (s) −2.82 0.64 −4.42 −2.11 0.47 −4.51 −1.41
log(s+ δ) 3.58 3.68 0.97 4.66 0.41 11.47 −0.42
Table 13: Variance components for revival model : no interaction
Censored Records Uncensored Records
Coefficient S.E. Coefficient S.E.
AR1 167.23 29.80 209.96 29.54
Patient 158.08 30.57 206.82 34.48
White Noise 223.08 17.28 179.59 12.90
Table 14: Coefficients for revival model : with interaction
Censored Records Uncensored Records
Covariate Coef. S.E. Ratio Coef.* S.E. Ratio T ?
Null Treatment 0.00 - - 0.00 - - -
Control −0.34 8.42 −0.04 1.79 1.51 1.19 −0.38
Prednizone 3.57 6.70 0.53 13.55 1.57 8.65 −1.94
Survival (T ) 3.10 0.52 5.98 1.78 0.48 3.70 3.05
Revival (s) −2.71 0.70 −3.85 −2.06 0.49 −4.24 −1.28
log(s+ δ) 0.21 5.62 0.04 4.07 1.06 3.85 −1.16
log(s+ δ):Control 1.98 3.95 0.50 −0.31 0.94 −0.33 0.90
log(s+ δ):Prednizone 3.82 3.10 1.23 1.39 0.92 1.51 1.03
Table 15: Variance components for revival model : with interaction
Censored Records Uncensored Records
Coefficient S.E. Coefficient S.E.
AR1 165.21 29.69 212.31 29.53
Patient 157.77 30.86 206.51 34.51
White Noise 223.13 17.26 176.96 12.79
31
E Robust estimation under adjusted nonparamet-
ric baseline hazard
As ρ tends to zero, the discrete component of the conditional hazard for the har-
monic process converges to the Kaplan-Meier product limit estimator. Unlike the
Kaplan-Meier, for ν > 0 the continuous component is non-zero when R](t) > 0 and
is undefined for t > Tmax = maxi Ti. On the other hand, if ν = λ · ρ then the
continuous component is zero for t < Tmax, and equal to λ for t > Tmax.
Define ν(t) = ρ ·λ(t; θ) so ν is time-dependent but proportional to ρ at each time t.
The marginal survival time has distribution given by the hazard function λ(t)(ψ(1+
ρ)− ψ(ρ)). The joint density is then given by∏k
i=1 ν(ti; θ)
ρ↑n
exp
(
−
∫ ∞
0
ν(s; θ)Ψ(R](s))ds
) k∏
i=1
Γ(di)
Assuming ρ fixed, the log-likelihood as a function of θ is
k∑
i=1
log(ν(ti; θ))−
∫ ∞
0
ν(s; θ)Ψ(R](s))ds
As ρ tends to zero, the term ρΨ(R](s)) tends to an indicator function of s < Tmax
so the log likelihood tends to
k∑
i=1
log(λ(ti; θ))−
∫ Tmax
0
λ(s; θ)ds
We assume that the marginal distribution of each survival time is Weibull so that
λ(t; θ) =
κ
λ
(
t
λ
)κ−1
In this case, the log-likelihood can be written as
k∑
i=1
log(λ(ti; θ))−
(
Tmax
λ
)κ
= k · [log(κ)−κ log(λ)]+(κ−1)
k∑
i=1
log(ti)−
(
Tmax
λ
)κ
Differentiating with respect to λ we have
−k
λ
+
Tκmax
λκ+1
= 0
which has solutions λˆ = 0 and
λˆ = [k/Tκmax]
−1/κ
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The first corresponds to the standard choice of supposing a point mass at infinity,
while the latter to the non-zero maximum likelihood estimate of interest.
Differentiating with respect to κ we have
k
κ
− k log(λ) +
k∑
i=1
log(ti)−
(
Tmax
λ
)κ
log
(
Tmax
λ
)
= log(Tmax) +
k∑
i=1
log(ti)− k
κ
solving for κ we have
κˆ =
[
log(T )− 1
k
k∑
i=1
log(ti)
]−1
The second term is the logarithm of the geometric mean of the distinct survival
times. Therefore, the estimator is guaranteed to be greater than zero. Moreover,
the maximum likelihood estimate is a simple function of the observed survival and
censoring times.
E.1 Examples
E.1.1 Prednisone Case Study
Applying the above estimators to the prednisone case study we have
κˆ = 4.75× 10−1 and λˆ = 1.05× 10−4
Figure E.1.1 plots the survival curves using the maximum likelihood estimes as-
suming the survival times are i.i.d. exponential and Weibull distributed along with
the kaplan meier estimator where the tail uses the above estimates. The estimated
survival curve is approximately equivalent to assuming the hazard is infinite after
the final observed time.
E.1.2 Gehan Case Study
Consider parameter estimation for a set of failure and censoring times (in weeks) of
the 6-MP subset of leukemia patients taken from Gehan (1965):
6, 6, 6, 6?, 7, 9?, 10, 10?, 11?, 13, 16, 17?, 19?, 20?, 22, 23, 25?, 32?, 32?, 34?, 35?
There are 9 uncensored observations, and a total risk time of 359 weeks. Applying
the above estimators to the leukemia dataset we have
κˆ = 0.96 and λˆ = 4.62
Figure E.1.2 plots the survival curves using the maximum likelihood estimes assum-
ing the survival times are i.i.d. exponential and Weibull distributed along with the
kaplan meier estimator where the tail uses the above estimates. Here the estimated
survival curve is not equivalent to assuming the hazard is infinite after the final
observed time.
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